MonacoTech has announced its third partnership with an international incubator, this time with ACET in Canada to support companies from the two accelerators in their overseas marketing efforts.
MonacoTech said on Thursday 27th May that it had signed the partnership with ACET, an accelerator for the creation of technological companies. The agreement formalises a collaboration that began a few months ago and will strengthen the cooperation between the two accelerators.
The collaboration will allow startups to benefit from the networks of the two incubators, increase opportunities and strengthen their competitive advantages through meetings with key players in the ecosystem.
“This collaboration with ACET is based on a common vision of innovation and support for our startups internationally,” said Lionel Galfré, Director of MonacoTech. “This agreement is fully in line with our strategy and our desire to offer project leaders supported by MonacoTech an opening to other markets and ecosystems abroad. Startups will now be able to benefit from the support and collaboration of an expert and renowned accelerator in Quebec, the gateway to the North American continent.”
The project will also aim to seek possible synergies between the different startups. Young companies will be supported when they want to validate their value proposition and test their products in new markets. These two accelerators will therefore have a role of proactive facilitator.
“This partnership is a wonderful opportunity for ACET and MonacoTech to exchange best practices in supporting technology companies,” said Ghyslain Goulet, CEO of ACET. “But above all, it is a golden opportunity for ACET companies to benefit from a leading business network from a very well-established accelerator in order to penetrate European markets.”
ACET’s mission is to identify innovative and daring technological projects, to support entrepreneurs in their development and to propel new innovative companies with a positive societal impact. Supported by a committed business community, ACET offers personalised support, from seed to internationalisation, access to various sources of funding including its own investment funds, the expertise of its market intelligence service and the power of its networks so that entrepreneurs can transform their passion, their vision and their innovations into a successful business.
The agreement follows similar partnerships with Capsula in Israel and APUI – IMT Lille Douai in France.
From cold soups with broth extraction and king crab, to lasagne and sugar-free meringue, guests of the new restaurant Yannick Alléno at the Hermitage Hotel are being treated to “simplicity” in modern cuisine.
He is a Rockstar of the gastronomic world, celebrated for his visionary approach to the culinary arts, twice rewarded three stars in France, holder of 14 Michelin stars, and member of the exclusive circle of the greatest chefs in the world.
With restaurants in Paris, Courchevel, Seoul and Dubai, his latest venture means that lovers of fine food need only travel as far as the Hermitage Hotel in Monte-Carlo.
On Tuesday 18th May, local press including Monaco Life were joined by Minister of State Pierre Dartout, National Council President Stéphane Valeri, SBM CEO Jean-Luc Biamonti, Hermitage Hotel General Director Louis Starck and government ministers for an exclusive introduction to Yannick Alléno at the Hermitage Hotel.
On the remodelled Mediterranean garden terrace of the hotel, surrounded by olive trees, citrus fruits and jasmine, Yannick Alléno laid out his gastronomic vision for Monaco in eight perfect plates.
Joined by five of his staff from Paris, Yannick Alléno walked into the kitchens of the Hermitage Hotel four months ago to start a new chapter in the life of Monaco’s prestigious palace, forming a powerhouse team with the chefs and staff of the former Vistamar.
“They are very happy for the opportunity to have a new challenge,” Yannick Alléno tells Monaco Life of his new team. “My priority was to be accepted by them and I feel that this has happened. After a certain period of time, they started to trust us.”
Trust is essential in the high-performance kitchens of Yannick Alléno, whose charismatic nature masks a burning compulsion for perfection. His dishes are elegant, precise and instantly understandable.
Yannick Alléno calls it “simplicity”.
Drawing on Monaco’s location, the weather, and the clientele, the chef has created cold pea soup with wild strawberries, lobster in cold bisque with roasted pistachio whipped cream, and cold vegetable ravioli with his trademark extraction broth and olive oil – clean, uncomplicated, renaissance cuisine.
“I think we are losing certain things,” says the chef. “Cold dishes, for example, have disappeared from the menu. But what do you want to have when the sun is shining and it is hot? Just a salad, or cold fish with a light sauce, a cold soup with a flavoursome broth… dishes that also give your metabolism what it needs? That is the direction that I like to go in.”
That “comfortable simplicity” extends to the hot dishes at the Hermitage, where his signature steamed cheese soufflé and blue lobster spaghetti sit alongside rack of lamb with lemon balm and ‘Luigi Taglienti’s’ lasagne (Michelin starred chef from Milan).
“We created the menu with our customers in mind,” says Yannick. “I thought to myself, ‘If I live in Monaco, what kind of restaurant do I want to go to?’. There are a lot of exceptional restaurants here, many starred restaurants, but for every day, what do you have? People who live here are also looking to find a place that is simple and comfortable. It is very tough to do simple.”
In 2013, with the help of French scientist Bruno Goussault, Yannick Alléno created a unique and revolutionary process called ‘Extraction’, which allows for the concentration and perfection of flavours. In regular kitchens, the concentration of flavours is achieved by evaporation using heat. Extraction, on the other hand, uses correct cooking temperatures to preserve the elements from destructive heat and brings the products to the fore so that they render and develop their purest flavours without the need to add any fat or other ingredients. Alléno’s modern sauces are a blending of several ‘Extractions’.
His avant-guard approach is summed up in the sugar-free desserts that he creates: Candied crust rhubarb with herbed sorbet, Monte-Carlo mousse with strawberries in vanilla, and gluten free almond paste crisp with cherry jelly.
Creative, technically perfect, structured and delicate, Yannick Alléno’s dishes are served in a particular sequence to offer the diner a majestic experience of flavours.
And with menus from 68€, the chef aims to make gastronomic cuisine available to everyone, even in the Principality of Monaco.
“When I was a commis chef at Le Royal Monceau in Paris, I wanted to impress a young lady at a one-star restaurant,” reveals Yannick. “It was December, and of course the maître d’ sold me a truffle menu. I had to pay what I get in one month for that meal, and trust me, I was afraid to go back into a restaurant again. That is what we have to break. The three stars are too far away from the expectations of normal people, we have to make it accessible to the younger generation, to everyone.
“The positive thing that Covid has taught me is reality – there are no Chinese, Japanese or American tourists right now, so what are we doing? We have to bring back our conversation with our neighbours and say: ‘Sorry, we have made a mistake, sorry we forgot about you. If you would like, you can have a 12€ starter, or if you want caviar, you can have caviar.”
Within the year, the Hermitage Hotel will flourish even more at the hands of Yannick Alléno’s designer from Paris, Chahan Minassian, who will transform the restaurant into a Mediterranean version of the Pavillon Ledoyen – Yannick’s six-starred establishment in Paris – complete with open kitchen.
“The Pavillon project is what I love,” says the chef. “I love to be behind the counter and in those conditions. A table is a circle, and it is very difficult to go inside a circle, for the service and for a chef. But when you are in front of people, you are in the life of people, with discretion of course. It is a different kind of relationship.”
His flagship restaurant Alléno Paris was awarded three Michelin stars after just seven months of opening. His two other restaurants within the Pavillon Ledoyen, the sushi restaurant L’Abysse and gastronomic counter Pavyllon, were awarded two stars and one star respectively in equally impressive time.
It is clearly only a matter of time before Chef Yannick Alléno is delivered another Michelin star in Monaco.
Chef Manon Fleury has signed on as new Head Chef at the Michelin-starred Monte-Carlo Beach restaurant Elsa, where her dedication to responsible, sustainable and delicious food options aligns perfectly with the philosophy of the restaurant.
Elsa Restaurant will have a new chef at the helm this summer season with the addition of Manon Fleury who is completely in line with the restaurant’s aesthetics and a desire to produce amazing meals sourcing locally-grown products and using the “zero waste” philosophy. This entails complete use of every ingredient, head to tail, stem to stone, and flower to leaf.
Fleury will be following in the revered footsteps of Eileen Gray, Elsa Maxwell, and India Mahdavi at the first 100% organic, wild fish-only starred restaurant in the world. She is, at the age of 30, already an experienced chef, having worked at Le Marmoz in Paris, and earning the Young Chef Prize at the 2019 first edition of the La Fourchette awards.
“The invitation of the Elsa restaurant to come and sublimate the exceptional products of the Monegasque region through demanding cuisine was obvious,” said Fleury. “I know that my cuisine, rooted in its territory and ecologically conscious, will be able to flourish there and that our collaboration will strengthen the convictions and commitments that the restaurant Elsa and I have in common. It is also a recognition of the work accomplished, which I hope will inspire other women to carry out their projects and take on the highest responsibilities.”
Danièle Garcelon, Managing Director of Monte-Carlo Beach, is thrilled to have a chef onboard who has such a like-minded approach, saying, “The Monte-Carlo Beach wants to take care of people and nature on a daily basis. Thanks to Manon Fleury, we are going to take our restaurant Elsa even further in an approach combining organic, local food and zero waste. Her talent, personality and convictions made the difference, the chemistry was immediate!”
The new menu will be inspired by local products that are sustainably sourced. To this end they will work with nearby estates and gardens, including the Jardin des Antipodes in Menton for aromatic herbs and fruit, and the Domaine d’Agerbol on the heights of Roquebrune-Cap-Martin, whose organic vegetable production gives Elsa a zero-kilometre source for the freshest produce.
Some of the delicacies that diners will be able to enjoy, when Fleury officially starts at Elsa, will be Gamberoni from San Remo with a raspberry and nasturtium flower jelly, a vegetable and herb pie from the garden of Agerbol, and a sea bream cooked in fig leaf with steamed rice and a virgin sauce.
The eco-friendly approach extends beyond the kitchen at Elsa, where a moderate use of water and energy resources are highlighted, as well as a policy of reducing or recycling waste in the most efficient ways.
The Monte-Carlo Beach itself has also made upgrades in the past year to keep in line with the environmentally astute philosophy, notably the finalisation of reclaiming the original beach from the 1930s whilst protecting the site using a sophisticated underwater reef dyke that promotes a fish population as well as being positive impactful.
Manon Fleury will be serving up her delicious new menu from 28th May.
Photo of Chef Manon Fleury provided by SBM
Discover Monaco’s cultural side at Associations’ Forum
The 8th Forum of Cultural Associations, an event designed to introduce the public to the many cultural organisations available in the Principality, will be held this July.
Organised by the Monaco Department of Cultural Affairs, the 8th edition of the Forum of Cultural Associations is a chance for people to discover the diverse range of groups, clubs and associations in their own back yard.
The event, which happens every two years, has something for everyone, and participants will share their passion for their activities in a variety of subjects such as plastic arts, creative hobbies, music, dance, art, theatre, food, literature and intercultural exchanges.
Each participating association will have their own stand and there is even the chance for them to make a short presentation explaining what they do. In the past, roughly 40 organisations have been on hand, and this year promises to be the same.
The event will be held from 5th and 6th June at the Rainier III Auditorium.
Clinical trials for a pill targeting the Covid-19 virus are in progress at Pfizer facilities in the United and States Belgium. Will this be a game-changer in the fight against the disease?
In two locales on two different continents, tests are taking place with up to 60 healthy adult volunteers, aged between 18 and 60. These volunteers have all signed up to try out a pill being developed specifically to stop the coronavirus pandemic that has wreaked havoc on the planet for the past year and a half.
If all goes as hoped for, there is a chance that an over-the-counter treatment for Covid will be hitting pharmacies and drug stores as soon as the latter part of this year.
The molecule that is making the magic happen has been dubbed PF 07321332. Not very glamorous, but if it works, this antiviral molecule could be the silver bullet the world has been waiting for. It was designed to attack the “spine” of the Covid virus to prevent it replicating in human hosts. The technology is similar to that currently used in treating another deadly virus, HIV, with the use of protease inhibitors.
The drug was almost certainly tested in labs before moving onto humans by giving a dose to infected live tissue cultures, including lung tissue cultures, to obtain results. The testing then moved onto animals, where it found “no significant risks or safety events of concern” nor did it “cause any side-effects at any dose levels that will be used in clinical studies.”
“If they have moved to this stage, they will be quietly optimistic,” Professor Penny Ward told The Telegraph. Ward is a visiting professor in pharmaceutical medicine at King’s College London and was part of the team who developed Tamiflu, the antiviral drug that combats seasonal and pandemic flu. “The question will be about how the drug is tolerated. They will be going like the clappers.”
This particular pill has been created specifically for Coivd-19. The first seven milligrams of the drug were turned out in July, an incredibly small amount, but by October, there were 100 grammes of the new drug. A fortnight later, an entire kilo had been produced, thanks to the work of 210 researchers working flat to the boards.
Pfizer is not revealing details of the trials, but they have said the pill has shown “potent in vitro antiviral activity against SARS-CoV-2.” Additionally, it has shown promise against other coronaviruses, meaning that a cure for the common cold may be within reach, as well as cures for future viruses that threaten global health.
“We have designed PF-07321332 as a potential oral therapy that could be prescribed at the first sign of infection, without requiring that patients are hospitalised or in critical care,” said Mikael Dolsten, Chief Scientific Officer and President of worldwide research, development and medical at Pfizer in an official statement released last month.
Those who have agreed to participate in the trials have a rigorous schedule. The trial is split into three phases and lasts for 145 days, with another 28 added for “screening and dosing.” All those involved will be asked to spend several nights in the lab facilities for observation.
PF-07321332 will be given to participants in combination with low doses of Ritonavir, an antiviral used to treat HIV. It acts as a “booster” to increase the amount of the drug in volunteers’ blood.
Phase 1 of the trial is designed to see how it “is tolerated as the dose is increased, alone or with ritonavir, if there are significant side effects, and how people feel after taking it”, say the official documents given to potential volunteers obtained by The Telegraph.
Phase 2 will be much of the same but with “multiple doses”. In phase 3, both tablet and liquid forms of the drug will be tested, as well as monitoring what the addition of food to the mix does.
Even if all goes swimmingly in the trials, there is still much to be done before it can be made public. Who is to say it will be ready for human consumption before the threat of the virus subsides? In any case, the possibility of a cure-all in a pill is enticing and could lead to the ability to stop future potential pandemics in their tracks.
Photo by Fusion Medical Animation on Unsplash
All the headlines and highlights from Monaco, direct to you every morning